Bicara Therapeutics Inc. share price logo

Bicara Therapeutics Inc.

NASDAQ: BCAX

$20.48

-2.30

(-10.07%)

as on

Bicara Therapeutics Inc. Stock Performance

as on September 24, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $20.54
    $23.11
    downward going graph

    -0.29%

    Downside

    12.84%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $10.45
    $30.99
    downward going graph

    48.97%

    Downside

    51.32%

    Upside

    downward going graph

Bicara Therapeutics Inc. share price movements today

Previous Close
$22.78
Open
$22.77
Volume
832.8K
Day's Low - High
$20.54 - $23.11
52 Week Low - High
$10.45 - $30.99

Bicara Therapeutics Inc. Historical Returns

1 Month Return
-3.39 %
3 Month Return
-11.15 %
1 Year Return
+ 103.57 %
3 Year Return
0 %
5 Year Return
0 %

Bicara Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Bicara Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

-3.1

Dividend Yield

0.00%

PE Ratio (TTM)

-7.35

Industry PE ratio

0.00

PEG Ratio

0.16764975484686828

Return On Equity TTM

-41.49%

Bicara Therapeutics Inc. Stock Valuation

Track how Bicara Therapeutics Inc. P/E has moved over time to understand its valuation trends.

Bicara Therapeutics Inc. in the last 4 years

  • Overview

  • Trends

Lowest (-32.02x)

December 31, 2022

Industry (0.00x)

December 31, 2025

Today (-6.68x)

December 31, 2025

Highest (-6.68x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -6.68x

Bicara Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bicara Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$-NA-7.350.00%0.00%
Neutral$72.9B-57.66%-22.88-12.57%0.00%
StrongBuy$-180.48%29.7386.04%0.00%
Buy$82.2B25.5%19.284.86%0.46%

Stock Returns calculator for Bicara Therapeutics Inc. Stock including INR - Dollar returns

The Bicara Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Bicara Therapeutics Inc. investment value today

Current value as on today

₹1,97,306

Returns

₹97,306

(+97.31%)

Returns from Bicara Therapeutics Inc. Stock

₹83,021 (+83.02%)

Dollar Impact

₹14,286 (+14.29%)

Analyst Recommendation on Bicara Therapeutics Inc. Stock

Based on 7 analysts

BUY

71.43%

Buy

28.57%

Hold

0.00%

Sell

Based on 7 analysts, 71.42857142857143% of analysts recommend a 'BUY' rating for Bicara Therapeutics Inc.. Average target price of $32.2857142857143

Bicara Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-15
-19
-20
-26
-41
-32
-40
-41
-60
-59
EBITDA
-12
-17
-17
-20
-36
-27
-36
-37
-56
-54
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-17
-17
-20
-36
-27
-36
-37
-56
-55
Income Tax Expense
0
-
-
0
0
0
0
0
0
0
Net Income
-12
-17
-17
-20
-36
-27
-36
-37
-56
-55
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Bicara Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Income
-37
-39
-82
-155
EBITDA
-37
-51
-67
-137
Interest Expense
0
-
-
-
Depreciation
0
0
0
0
Income Before Tax
-37
-51
-67
-137
Income Tax Expense
0
0
0
0
Net Income
-37
-51
-67
-137
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Bicara Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-12
-17
-17
-20
-36
-27
-36
-37
-56
-55
Operating Cash Flow
-14
-12
-17
-30
-28
-25
-29
-23
-37
-44
Investing Cash Flow
0
0
0
0
-
-
-236
-82
100
-184
Financing Cash Flow
0
0
334
0
0
0
0
31
163
2
Change in Cash
-14
-12
316
-31
-27
-25
-264
-74
226
-226

Bicara Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-37
-51
-67
-137
Operating Cash Flow
-32
-45
-74
-106
Investing Cash Flow
0
0
0
-318
Financing Cash Flow
31
272
334
32
Change in Cash
0
226
259
-393

Mutual Funds that own Bicara Therapeutics Inc. Stock

Check out the Mutual Funds with significant holdings in Bicara Therapeutics Inc..

Funds
Holdings
Shares Held
T. ROWE PRICE SMALL-CAP STOCK FUND, INC.
3.296958%
2181694
VANGUARD INDEX FUNDS
2.610642%
1727539
T. Rowe Price Equity Funds, Inc.
1.807894%
1196337
Fidelity Select Portfolios
1.427925%
944900
Franklin Strategic Series
1.348711%
892482

Global Institutional Holdings in Bicara Therapeutics Inc.

Funds
Holdings
Peter Kolchinsky
10.97%
Vanguard
3.97%
T. ROWE PRICE SMALL-CAP STOCK FUND, INC.
3.3%
iShares
3.1%
Otello Stampacchia
2.75%

Insights on Bicara Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 603.7% return, outperforming this stock by 520.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BCAX stock has moved down by -9.3%

About Bicara Therapeutics Inc.

Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. Established in 2018, the company specializes in creating innovative, dual-action treatments specifically for solid tumors. At the forefront of their pipeline is ficerafusp alfa, a unique antibody designed to tackle solid cancers. This bifunctional therapeutic agent works by simultaneously engaging the epidermal growth factor receptor (EGFR) and binding to human transforming growth factor beta (TGF-b). Bicara Therapeutics operates as a subsidiary of Biocon Limited.
OrganisationBicara Therapeutics Inc.
Headquarters116 Huntington Avenue, Boston, MA, 02116, US
IndustryBiotechnology
CEOClaire Mazumdar Clemon
E-voting on sharesClick here to vote

FAQs

What is Bicara Therapeutics Inc. share price today?

Bicara Therapeutics Inc. share price today is $20.48 as on at the close of the market. Bicara Therapeutics Inc. share today touched a day high of $23.11 and a low of $20.54.

What is the 52 week high and 52 week low for Bicara Therapeutics Inc. share?

Bicara Therapeutics Inc. share touched a 52 week high of $30.99 on and a 52 week low of $10.45 on . Bicara Therapeutics Inc. stock price today i.e. is closed at $20.48,which is 33.91% down from its 52 week high and 95.98% up from its 52 week low.

How to invest in Bicara Therapeutics Inc. Stock (BCAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bicara Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bicara Therapeutics Inc. Shares that will get you 0.0732 shares as per Bicara Therapeutics Inc. share price of $20.48 per share as on September 24, 2026 at 8:45 am IST.

What is the minimum amount required to buy Bicara Therapeutics Inc. Stock (BCAX) from India?

Indian investors can start investing in Bicara Therapeutics Inc. (BCAX) shares with as little as ₹95.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.40 in Bicara Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Bicara Therapeutics Inc. share’s latest price of $20.48 as on September 24, 2026 at 8:45 am IST, you will get 0.4883 shares of Bicara Therapeutics Inc.. Learn more about fractional shares .